banner ad
banner ad

jeff

rss feed

Laser Liposuction May Zap Fat Without Skin Sag

April 16, 2013 |

Preliminary research suggests procedure could have advantages over traditional method of fat removal Laser-assisted liposuction might provide an option for people who want stubborn pockets of fat removed but fear they’ll be left with loose skin. Traditional liposuction, a fat-removing cosmetic surgery procedure, is generally reserved for people with firm skin to reduce the risk […]

Read More

The Obesity Epidemic

April 5, 2013 |

While America swallows $147 billion in obesity-related healthcare costs, physicians called on to confront the crisis The United States has a weight problem. And physicians are being called on to adapt their practices to confront it. According to the Centers for Disease Control and Prevention (CDC), in 2010, more than 78 million U.S. adults and […]

Read More

Johnson & Johnson may cause wrinkles in the Botox market

March 27, 2013 |

Johnson & Johnson may soon cause frown lines at Allergan, maker of Botox, as it expects to seek US approval next year for an anti-wrinkle drug that could break Botox’s near monopoly, an 85% market share. The Johnson & Johnson product could be available in the US in 2015 and other countries a few years […]

Read More

Valeant to acquire Obagi for $344M

March 27, 2013 |

Valeant Pharmaceuticals is acquiring Obagi Medical Products for nearly $344 million, just months after acquiring Medicis Pharmaceutical for $2.6 billion. The definitive agreement would allow Valeant to acquire all outstanding common stock of Obagi for $19.75 per share in cash. The deal is expected to close in the first half of 2013, according to a […]

Read More

Laser Hair Removal

March 27, 2013 |

If you’re not happy with shaving, tweezing, or waxing to remove unwanted hair, laser hair removal may be an option worth considering. Laser hair removal is one of the most commonly done cosmetic procedures in the U.S. It beams highly concentrated light into hair follicles. Pigment in the follicles absorb the light. That destroys the […]

Read More

Most popular cosmetic surgery procedures in 2012

March 12, 2013 |

The 2012 National Totals for Cosmetic Procedures, hot off the press from the American Society for Aesthetic Plastic Surgery (ASAPS), answers an interesting question: “What cosmetic procedures do Americans think are important enough to invest hard-earned dollars in?” Breasts regain their number one status Breast augmentation has regained its status in 2012 as the leading […]

Read More

Allergan thrives with Botox but is unloading Lap-Band

March 7, 2013 |

Drug maker Allergan posted record sales in 2012, with wrinkle remover Botox its top seller, but plans to sell its Lap-Band unit amid falling sales and patient deaths. This is the company that makes Botox. The wrinkle-erasing drug is Allergan’s top-selling product with sales expected to reach $2 billion in 2013. But there’s more to […]

Read More

US study: Botox reduces symptoms of depression

March 6, 2013 |

A recent study in the US has found that using Botox to combat frown lines reduced the symptoms of severe depression in more than a quarter of patients. The decade long research into the benefits of Botox for the severely depressed found that injecting Botox into your furrows or ‘grief muscles’ can actually make you […]

Read More

Stem Cells Printer: What the New Innovation Means for Aesthetic Medicine

March 5, 2013 |

On February 5, 2013 Scientific American has published a report that the University of Edinburgh has successfully finished a study which led to the production of a live embryonic stem cells-discharging printer. The breakthrough printer releases uniformly-sized cell droplets such that the living cells could be used to mutate into a number of cell types. […]

Read More

EU Rejects Obesity Drug Qsiva for the Second Time

February 26, 2013 |

The European Medicines Agency (EMA) has again refused to grant approval for the new obesity treatment phentermine/extended-release (ER) topiramate (Qsiva, Vivus) in the European Union. The EMA’s Committee for Medicinal Products for Human Use (CHMP) first rejected the product in October but was asked  by the company to reexamine the decision. Defending its second rebuttal, the CHMP said it “has   […]

Read More

banner ad
banner ad